Amplify the possible in advanced therapy preclinical studies
AmplifyBio is a CRO and CDMO founded on the principle that product characterization is the key to safety, efficacy, and consistency when scaling advanced therapies. In vivo safety efficacy and toxicology studies are offered in a preclinical CRO facility. AmplifyBio’s multi-modality cGMP manufacturing suites are available with flexible staffing models in their manufacturing center, where clients can find maximum flexibility and a space they can grow in, not out of.